Authors : Alzoman NZ; Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.; Darwish IA

Subjects: Selective Serotonin Reuptake Inhibitors* ; Fluvoxamine*; Spectrometry, Fluorescence/Spectrometry, Fluorescence/Spectrometry, Fluorescence/methods

Source: Molecules (Basel, Switzerland) [Molecules] 2023 Jul 05; Vol. 28 (13). Date of Electronic Publication: 2023 Jul 05.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049

Record details

Read Online Read More Add to Saved list

Academic Journal

Virtual twins for model-informed precision dosing of clozapine in patients with treatment-resistant schizophrenia.

Authors : Mostafa S; Centre for Medicine Use and Safety, Monash University, Parkville, Victoria, Australia.; MyDNA Life Australia Limited, Victoria, Australia.

Subjects: Clozapine*/Clozapine*/Clozapine*/pharmacokinetics ; Clozapine*/Clozapine*/Clozapine*/therapeutic use ; Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/pharmacokinetics

Source: CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2024 Mar; Vol. 13 (3), pp. 424-436. Date of Electronic Publication: 2024 Jan 19.Publisher: Wiley Country of Publication: United States NLM ID: 101580011 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list

Academic Journal

Potential Role of the Antidepressants Fluoxetine and Fluvoxamine in the Treatment of COVID-19.

Authors : Mahdi M; Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Egyetem tér 1, 4032 Debrecen, Hungary.; Infectology Clinic, University of Debrecen Clinical Centre, Bartók Béla út 2-26, 4031 Debrecen, Hungary.

Subjects: Fluvoxamine*/Fluvoxamine*/Fluvoxamine*/pharmacology ; Fluvoxamine*/Fluvoxamine*/Fluvoxamine*/therapeutic use ; COVID-19 Drug Treatment*

Source: International journal of molecular sciences [Int J Mol Sci] 2022 Mar 30; Vol. 23 (7). Date of Electronic Publication: 2022 Mar 30.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

Read Online Read More Add to Saved list

Editorial & Opinion

Old drug fluvoxamine, new hope for COVID-19.

Authors : Hashimoto Y; Department of Respirology, Chiba University Graduate School of Medicine, Chiba, 260-8670, Japan.; Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, 1-8-1 Inohana, Chiba, 260-8670, Japan.

Subjects: Fluvoxamine*/Fluvoxamine*/Fluvoxamine*/therapeutic use ; COVID-19 Drug Treatment*; Humans

Source: European archives of psychiatry and clinical neuroscience [Eur Arch Psychiatry Clin Neurosci] 2022 Feb; Vol. 272 (1), pp. 161-163. Date of Electronic Publication: 2021 Sep 02.Publisher: Springer International Country of Publication: Germany NLM ID: 9103030 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list

Academic Journal

Sigma-1 Receptor Agonist Fluvoxamine Ameliorates Fibrotic Response of Trabecular Meshwork Cells.

Authors : Hodrea J; MTA-SE Lendület 'Momentum' Diabetes Research Group, Semmelweis University, 1083 Budapest, Hungary.; Pediatric Center, MTA Center of Excellence, Faculty of Medicine, Semmelweis University, 1083 Budapest, Hungary.

Subjects: Glaucoma, Open-Angle*/Glaucoma, Open-Angle*/Glaucoma, Open-Angle*/metabolism ; Glaucoma*/Glaucoma*/Glaucoma*/metabolism; Humans

Source: International journal of molecular sciences [Int J Mol Sci] 2023 Jul 19; Vol. 24 (14). Date of Electronic Publication: 2023 Jul 19.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

Read Online Read More Add to Saved list

Academic Journal

Treatment-Resistant Depression (TRD): Is the Opioid System Involved?

Authors : Schreiber S; Department of Psychiatry, Tel Aviv Sourasky Medical Center, Tel Aviv 6423906, Israel.; Dr. Miriam and Sheldon G. Adelson Clinic for Drug Abuse Treatment and Research, Tel Aviv Sourasky Medical Center, Tel Aviv 6423906, Israel.

Subjects: Analgesics, Opioid*/Analgesics, Opioid*/Analgesics, Opioid*/pharmacology ; Analgesics, Opioid*/Analgesics, Opioid*/Analgesics, Opioid*/therapeutic use ; Trazodone*

Source: International journal of molecular sciences [Int J Mol Sci] 2023 Jul 06; Vol. 24 (13). Date of Electronic Publication: 2023 Jul 06.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

Read Online Read More Add to Saved list

Academic Journal

Effect of fluvoxamine on preventing neuropsychiatric symptoms of post COVID syndrome in mild to moderate patients, a randomized placebo-controlled double-blind clinical trial.

Authors : Farahani RH; AJA University of Medical Sciences, Tehran, Iran.; Ajam A

Subjects: COVID-19* ; Communicable Diseases*/Communicable Diseases*/Communicable Diseases*/drug therapy; Humans

Source: BMC infectious diseases [BMC Infect Dis] 2023 Mar 31; Vol. 23 (1), pp. 197. Date of Electronic Publication: 2023 Mar 31.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

Record details

Read Online Read More Add to Saved list

Academic Journal

Intuitive repositioning of an anti-depressant drug in combination with tivozanib: precision medicine for breast cancer therapy.

Authors : Kumar N; Precision NeuroOncology & NeuroVascular Disease Modeling Group, Department of Life Sciences, School of Natural Sciences, Shiv Nadar University, Delhi-NCR, 201314, India.; Raza M

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*pharmacology ; Drug Repositioning/Drug Repositioning/Drug Repositioning/*methods ; Fluvoxamine/Fluvoxamine/Fluvoxamine/*pharmacology

Source: Molecular and cellular biochemistry [Mol Cell Biochem] 2021 Nov; Vol. 476 (11), pp. 4177-4189. Date of Electronic Publication: 2021 Jul 29.Publisher: Springer Country of Publication: Netherlands NLM ID: 0364456 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list

Academic Journal

Exploring the association between selective serotonin reuptake inhibitors and rhabdomyolysis risk based on the FDA pharmacovigilance database.

Authors : Wang Y; Department of Pharmacy, Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524001, China.; Lin Y

Subjects: Selective Serotonin Reuptake Inhibitors*/Selective Serotonin Reuptake Inhibitors*/Selective Serotonin Reuptake Inhibitors*/adverse effects ; Rhabdomyolysis*/Rhabdomyolysis*/Rhabdomyolysis*/chemically induced ; Rhabdomyolysis*/Rhabdomyolysis*/Rhabdomyolysis*/epidemiology

Source: Scientific reports [Sci Rep] 2023 Jul 28; Vol. 13 (1), pp. 12257. Date of Electronic Publication: 2023 Jul 28.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list

Academic Journal

Distribution of Fluvoxamine and Identification of the Main Metabolite in a Fatal Intoxication.

Authors : Vignali C; Department of Public Health, Experimental and Forensic Medicine, University of Pavia, via Forlanini, 12, 27100 Pavia, Italy.; Moretti M

Subjects: Fluvoxamine* ; Selective Serotonin Reuptake Inhibitors*; Bile

Source: Journal of analytical toxicology [J Anal Toxicol] 2021 Apr 12; Vol. 45 (4), pp. e1-e5.Publisher: Oxford University Press Country of Publication: England NLM ID: 7705085 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list